Cell Surface Markers

Works Cited

Belov, Larissa. "Immunopheontyping of Leukemias Using a Cluster of Differentiation Antibody Microarray." Cancer Research (2001). Print.
Bernard. "Supplemental Content." National Center for Biotechnology Information. U.S. National Library of Medicine, 27 Oct. 1984. Web. 02 Apr. 2012. <http://www.ncbi.nlm.nih.gov/pubmed/6239187>.
Brandley, Brian K. "Cell-Surface Carbohydrates in Cell Recognition and Response." Journal of Leukocyte Biology (1986). Print.
Dietel, Manfred. "Personalized Medicine and Development of Targeted Therapies: The Upcoming Challenge for Diagnostic Molecular Pathology. A Review." (2006). Print.
"Frequently Asked Questions." What Are the Potential Uses of Human Stem Cells and the Obstacles That Must Be Overcome before These Potential Uses Will Be Realized? [Stem Cell Information]. National Institutes of Health. Web. 03 Apr. 2012. <http://stemcells.nih.gov/info/basics/basics6.asp>.
Green, Ronald M. "The Stem-Cell Debate." PBS. PBS, Nov. 2001. Web. 03 Apr. 2012. <http://www.pbs.org/wgbh/nova/miracle/stemcells.html>.
"Hematopathology: Immunophenotyping Lymphomas." UMDNJ. UMNDJ. Web. 24 Mar. 2012. <http://pleiad.umdnj.edu/hemepath/immuno/immuno.html>.
Hillner, Bruce E. "Journal of Clinical Oncology." Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated With 21st-Century Cancer Drug Pricing. Journal of Clinical Oncology, 2009. Web. 03 Apr. 2012. <http://jco.ascopubs.org/content/27/13/2111>.
Klein, Stefan A. "Demonstration of the Th1 to Th2 Cytokine Shift during the Course of HIV-1 Infection Using Cytoplasmic Cytokine Detection on Single Cell Level by Flow Cytometry." AIDS (1997). Print.
Lynch, Carmel M. "Practical Considerations for Nonclinical Safety Evaluation of Therapeutic Monoclonal Antibodies." PubMed. PubMed, Jan.-Feb. 2009. Web. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715182/>.
Mason, K., S. Juneja, and J. Szer. "The Immunophenotype of Acute Myeloid Leukemia: Is There a Relationship with Prognosis?" Blood Reviews 20.2 (2006): 71-82. Print.
Mazeau, J. C. "Immunophenotyping and Metastatic Localization of Breast Cancer." Cancer Research (1994). Print.
Nolan, John. "Flow Cytometry: A Versatile Tool for All Phases of Drug Discovery." 4.4 (1999): 173-80. Print.
Reilly, J. "UK NEQAS for Leucocyte Immunophenotyping: The First 10 Years." Journal of Clinical Pathology. PubMed, July 2001. Web. 25 Mar. 2012. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1731480/>.
Schattner, Elaine. "Defining a Cluster of Differentiation, or CD." Medical Lessons. Medical Lessons, 17 May 2011. Web. 24 Mar. 2012. <http://www.medicallessons.net/2011/05/tuesdays-term-defining-a-cluster-of-differentiation-or-cd/>.
Sklar, L., M. Carter, and B. Edwards. "Flow Cytometry for Drug Discovery, Receptor Pharmacology and High-throughput Screening." Current Opinion in Pharmacology 7.5 (2007): 527-34. Print.
Valet, G. "Cytomics as a New Potential for Drug Discovery." Drug Discovery Today 11.17-18 (2006): 785-91. Print.